Aqua cycling for immunological recovery after intensive, eccentric exercise.


Journal

European journal of applied physiology
ISSN: 1439-6327
Titre abrégé: Eur J Appl Physiol
Pays: Germany
ID NLM: 100954790

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 04 12 2018
accepted: 13 03 2019
pubmed: 22 3 2019
medline: 28 8 2019
entrez: 22 3 2019
Statut: ppublish

Résumé

Alterations in immunological homeostasis induced by acute exercise have been frequently reported. In view of the growing amount of repetitive exercise stimuli in competitive sports, quick recovery plays a superior role. Therefore, we examined whether aqua cycling affects cellular immunological recovery. After performing 300 countermovement jumps with maximal effort male sport students (n = 20; 24.4 ± 2.2 years) were randomized into either an aqua cycling (AC) or a passive recovery (P) group. AC pedaled in chest-deep water without resistance, while P lay in a supine position. Each recovery protocols lasted 30 min. Blood samples were taken at Baseline, Post-exercise, Post-recovery and 1 h (h), 2 h, 4 h, 24 h, 48 h and 72 h after recovery. Outcomes comprised white blood cell (WBC) counts, lymphocyte (LYM) counts and LYM subsets (CD4/CD8 ratio). Additionally, cellular inflammation markers (neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR) and systemic immune-inflammation index (SII)) were calculated. In both groups, WBC, NLR and SII were significantly increased compared to Baseline up to and including 4 h after recovery. Significant interaction effects were found for WBC (Post-recovery, 2 h and 4 h), NLR (Post-recovery), SII (Post-recovery) and CD4/CD8 ratio (2 h) with values of AC being higher than of P. Interestingly, AC provoked a stronger but not prolonged immunological disturbance than P. NLR and SII may present simple, more integrative markers to screen exercise-induced alterations in immune homeostasis/recovery in athletes and clinical populations. More research is warranted to elucidate the clinical and practical relevance of these findings.

Identifiants

pubmed: 30895460
doi: 10.1007/s00421-019-04127-4
pii: 10.1007/s00421-019-04127-4
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1369-1375

Références

Int J Sports Med. 1995 Oct;16(7):466-74
pubmed: 8550256
Exerc Immunol Rev. 2010;16:119-37
pubmed: 20839496
Sci Rep. 2018 Jul 12;8(1):10566
pubmed: 30002404
Sports Med. 2006;36(9):747-65
pubmed: 16937951
Exp Clin Endocrinol Diabetes. 2013 Aug;121(8):475-82
pubmed: 24026829
Int J Sports Med. 1995 Jul;16(5):322-8
pubmed: 7558530
Sci Rep. 2016 Dec 21;6:39482
pubmed: 28000729
J Strength Cond Res. 2017 Jan;31(1):162-170
pubmed: 27135478
Br J Sports Med. 2007 Feb;41(2):69-75; discussion 75
pubmed: 17138630
Med Sci Sports Exerc. 1995 Mar;27(3):363-70
pubmed: 7752863
Eur J Appl Physiol. 2009 Nov;107(4):397-409
pubmed: 19649649
J Physiol. 1999 Feb 15;515 ( Pt 1):287-91
pubmed: 9925898
J Appl Physiol (1985). 2017 May 1;122(5):1077-1087
pubmed: 27909225
Sports Med. 2006;36(9):781-96
pubmed: 16937953
Int Immunopharmacol. 2018 Sep;62:293-298
pubmed: 30048859
J Physiol. 2000 Nov 15;529 Pt 1:243-62
pubmed: 11080266
Exerc Sport Sci Rev. 2007 Jul;35(3):150-5
pubmed: 17620934
Br J Sports Med. 2000 Aug;34(4):246-51
pubmed: 10953894
PLoS One. 2017 May 16;12(5):e0177704
pubmed: 28520802
Exerc Immunol Rev. 2011;17:6-63
pubmed: 21446352
Sports Med. 2003;33(2):145-64
pubmed: 12617692
Sports Med. 2013 Nov;43(11):1101-30
pubmed: 23743793
Acta Physiol Scand. 1998 Mar;162(3):325-32
pubmed: 9578378
Front Immunol. 2018 Apr 16;9:648
pubmed: 29713319

Auteurs

Niklas Joisten (N)

Department of Molecular and Cellular Sport Medicine, Institute of Cardiovascular Research and Sport Medicine, German Sport University Cologne, Am Sportpark Müngersdorf 6, 50933, Cologne, Germany.

David Walzik (D)

Department of Molecular and Cellular Sport Medicine, Institute of Cardiovascular Research and Sport Medicine, German Sport University Cologne, Am Sportpark Müngersdorf 6, 50933, Cologne, Germany.

Alexander Schenk (A)

Department of Molecular and Cellular Sport Medicine, Institute of Cardiovascular Research and Sport Medicine, German Sport University Cologne, Am Sportpark Müngersdorf 6, 50933, Cologne, Germany.

Wilhelm Bloch (W)

Department of Molecular and Cellular Sport Medicine, Institute of Cardiovascular Research and Sport Medicine, German Sport University Cologne, Am Sportpark Müngersdorf 6, 50933, Cologne, Germany.

Philipp Zimmer (P)

Department of Molecular and Cellular Sport Medicine, Institute of Cardiovascular Research and Sport Medicine, German Sport University Cologne, Am Sportpark Müngersdorf 6, 50933, Cologne, Germany. p.zimmer@dshs-koeln.de.
Division of Physical Activity, Prevention and Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany. p.zimmer@dshs-koeln.de.

Patrick Wahl (P)

Department of Molecular and Cellular Sport Medicine, Institute of Cardiovascular Research and Sport Medicine, German Sport University Cologne, Am Sportpark Müngersdorf 6, 50933, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH